Certificates
Nestmedic holds certifications for compliance with EU MDR 2017/745, ISO 13485, ISO/IEC 27001, and Free Sale.
nestmedic.comCrawled Nov 18, 2026
Nestmedic holds certifications for compliance with EU MDR 2017/745, ISO 13485, ISO/IEC 27001, and Free Sale.
Pregnabit Pro includes data flow diagrams for hospital and home use, along with technical specifications for Pregnabit Cloud and mobile CTG.
The Pregnabit system records CTG readings anytime, anywhere, especially at home, and includes a Medical Telemonitoring Center for real-time analysis by qualified medical staff.
Pregnabit Cloud is a SaaS system designed to work with telemedical CTG devices, receiving and analyzing measurement data for interpretation by midwives and doctors.
Pregnabit Pro is a telemedical device supporting doctors and midwives, available for teleKTG examinations or home use by patients in the third trimester.
Nestmedic S.A. sets May 29, 2026, as the new deadline for publishing its 2025 annual report.
Nestmedic supports medical staff to ensure safe pregnancy outcomes and provides innovative medical services to women worldwide.
Nestmedic S.A. announces that its Ordinary General Meeting appointed Joanna Tlak to the Supervisory Board on June 28, 2023.
Nestmedic S.A. announces that its Extraordinary General Meeting appointed Aleksandra Puton-Pabijan to the Supervisory Board on May 5, 2025.
Nestmedic S.A. reports that Karol Hop resigned from the Supervisory Board on April 10, 2025.
Nestmedic S.A. reports that Beata Turlejska resigned from the Supervisory Board on April 4, 2023.
Nestmedic S.A. conducts R&D work to develop the second-generation Pregnabit telemedical system, including wireless probes for fetal monitoring, a dedicated pulse oximeter, and real-time data transmission.
Pregnabit Pro is a complete system for monitoring fetal and maternal well-being in late pregnancy, designed for both healthcare professionals and patients.
Nestmedic S.A. produces Pregnabit, a telemedical solution for remote fetal well-being monitoring using cardiotocography (CTG).
Nestmedic S.A. is headquartered in Warsaw, Poland, with a registered capital of 5,061,366.20 zł.
Nestmedic is a technology company specializing in telemedicine and digital health, improving access to advanced CTG diagnostics for pregnant women while reducing costs.
Pregnabit Pro and Pregnaone medical devices include workflows for hospital and home use, along with technical specifications for Pregnabit Cloud and mobile CTG.